FORMULATION AND EVALUATION OF SUSTAINED RELEASE MATRIX TABLETS OF NATEGLINIDE
The objective of this work was to prepare and evaluate oral sustained release matrix tablet of Nateglinide and to study the effect of proportion of wax and addition of release liner on in-vitro release of drug.The prepared tablets were evaluated for pre and post compression parameters. Stability study of the promising formulation was also performed. The matrix tablets were prepared by Direct compression, Co-processed & melt granulation, method using wax in concentration 25%, 35% & 45% and evaluated for on in-vitro drug release using Compritol & Precirol. No interactions were found between drug and excipients. Formulation containing 25% Precirol F13 shows releases up to 12 hours. Tablets with release characteristics offers critical advantages such as site specificity with improved absorption and efficacy etc.Keywords: Nateglinide, Sustained release, Compritol 888, Precirol ATO 5, Melt Granulation, Direct compression,
Authors who publish with this journal agree to the following terms:
- Authors retain copyright and grant the journal right of first publication with the work simultaneously licensed under a Creative Commons Attribution-NonCommercial 4.0 International (CC BY-NC 4.0). that allows others to share the work with an acknowledgment of the work's authorship and initial publication in this journal.
- Authors are able to enter into separate, additional contractual arrangements for the non-exclusive distribution of the journal's published version of the work (e.g., post it to an institutional repository or publish it in a book), with an acknowledgment of its initial publication in this journal.
- Authors are permitted and encouraged to post their work online (e.g., in institutional repositories or on their website) prior to and during the submission process, as it can lead to productive exchanges, as well as earlier and greater citation of published work (See The Effect of Open Access).